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Abstract
In order to investigate the genetic diversity and patterns of the co-circulating genotypes of
respiratory syncytial virus (RSV) and their possible relationships with the severity of RSV in-
fection, we studied all of the RSV-positive nasopharyngeal samples collected from children
during five consecutive winters (2009–2010, 2010–2011, 2011–2012, 2012–2013 and
2013–2014). The RSVs were detected using the respiratory virus panel fast assay and sin-
gle-tube RT-PCR, their nucleotides were sequenced, and they were tested for positive se-
lection. Of the 165 positive samples, 131 (79.4%) carried RSV-A and 34 (20.6%) RSV-B;
both groups co-circulated in all of the study periods, with RSV-A predominating in all the
seasons except for winter 2010–2011, which had a predominance of RSV-B. Phylogenetic
analysis of the RSV-A sequences identified genotypes NA1 and ON1, the second replacing
the first during the last two years of the study period. The RSV-B belonged to genotypes
BA9 and BA10. BA9 was detected in all the years of the study whereas BA only desultorily.
Comparison of the subjects infected by RSV-A and RSV-B types did not reveal any signifi-
cant differences, but the children infected by genotype A/NA1 more frequently had lower re-
spiratory tract infections (p<0.0001) and required hospitalisation (p = 0.007) more often
than those infected by genotype A/ON1. These findings show that RSV has complex pat-
terns of circulation characterised by the periodical replacement of the predominant geno-
types, and indicate that the circulation and pathogenic role of the different RSV strains
should be investigated as each may have a different impact on the host. A knowledge of the
correlations between types, genotypes and disease severity may also be important in order
to be able to include the more virulent strains in future vaccines.
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Introduction
Human respiratory syncytial virus (RSV) is the second most frequent cause of respiratory in-
fections, and the main cause of severe cases of bronchiolitis and pneumonia in infants and
young children [1].
Classified in the Pneumovirus genus of the family Paramyxoviridae, it is an enveloped virus
with a negative-sense single-strained RNA genome that encodes for 11 proteins [2], including
two surface glycoproteins that are antigenically significant because they induce neutralising an-
tibody responses: fusion protein (F protein) and attachment glycoprotein (G protein). F pro-
tein is conserved, whereas the C-terminal third hypervariable region of the G protein is subject
to rapid mutation [2]. On the basis of their reactions with monoclonal antibodies, the viral
strains have been separated into two major serotypes (RSV-A and RSV-B), and nucleotide
sequence analysis has led to the identification of 11 RSV-A (GA1-GA7, SAA1, NA1-NA2,
and ON1) [2–4] and 23 RSV-B genotypes, (GB1-GB4, SAB1-SAB3, SAB4, URU1, URU2,
BA1-BA12 and THB) [5–13]. Multiple genotypes can co-circulate during successive epidemic
seasons, but a new genotype (or one spreading from another country) may replace previously
dominant strains [5,14,15].
The rapid spread of a novel RSV-A genotype (A/ON1, replacing the ancestor A/NA1) has
recently been documented in a number of countries [13,16–21]. RSV molecular epidemiologi-
cal surveillance is essential for detecting the emergence of new viral strains, identifying or pre-
dicting their clinical relevance, selecting candidate strains for vaccine development, and
preparing public health intervention strategies based on phylogeographic analysis.
The clinical manifestations of RSV infection can range from mild upper respiratory tract ill-
ness (URTIs) or acute otitis media to severe and potentially life-threatening lower respiratory
tract involvement (LRTIs) [22]. It has been demonstrated that various host characteristics and
a number of factors, including viral types and genotypes, can influence the clinical course of
RSV infection in children [1,22,23], but the real importance of each of them are still unclear.
The main aim of this study was to investigate the genetic diversity and patterns of the co-circu-
lating genotypes of RSV-A and RSV-B strains in Milan, and the possible associations between
individual RSV genotypes and the clinical course of RSV infection.
Methods
Study design
In order to evaluate the circulation of the different RSV types and genotypes, and the possible
relationships between their genetic characteristics and the severity of RSV infection, we studied
all of the nasopharyngeal samples exclusively positive for RSV collected from children aged
<2 years attending the Emergency Room of the University of Milan’s Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico because of influenza-like illness arising between No-
vember 1 and March 31 of five consecutive winters (2009–2010, 2010–2011, 2011–2012,
2012–2013 and 2013–2014). The samples were selected from those previously collected during
a study specifically designed to analyse the impact of respiratory viruses in children aged
<15 years with an influenza-like illness (as defined by the Italian Ministry of Health, http//
www.ministerosalute.it) and without any underlying severe chronic disease [24]. In accordance
with the Italian Ministry of Health, an ILI was defined as an acute respiratory disease of sudden
onset, with fever (an axillary temperature of>38°C) and accompanied by at least one of
the general symptoms of headache, generalized malaise, a feverish sensation (sweating and
chills) or asthenia, and at one of the respiratory symptoms of cough, pharyngodynia or nasal
congestion.
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Upon enrolment, the patients’ demographic characteristics and medical history were sys-
tematically recorded using standardised written questionnaires [24] and, after a complete clini-
cal examination, they were classified into disease groups (acute otitis media, rhinosinusitis,
pharyngitis, croup, infectious wheezing, acute bronchitis, pneumonia, diarrhea and gastroen-
teritis) on the basis of signs and/or symptoms using well-established criteria [24].
A nasopharyngeal sample was collected from all of the children using a pernasal flocked
swab, which was stored in a tube containing 1 mL of universal transport medium (Copan Italia,
Brescia, Italy).
The children’s medical history was re-evaluated by means of follow-up interviews and a
clinical examination by trained investigators using standardized questionnaires [24] 5–7 days
after enrolment, and then every two days until the resolution of their illness. All of the data of
the study children were verified against their medical records.
Both the original study and this extension were approved by the Ethics Committee of the
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, and written informed consent
obtained from a parent or legal guardian of the enrolled children (those aged>8 years were
asked to give their assent).
Identification of respiratory viruses
Viral nucleic acids were extracted from the samples by means of a NucliSENS EasyMAG auto-
mated extraction system (BioMéerieux, Craponne, France), and the extract was tested for respi-
ratory viruses using the respiratory virus panel xTAG RVP FAST v2 (Luminex Molecular
Diagnostics, Inc., Totonto, Canada), which simultaneously detects influenza A virus (subtypes
H1 or H3), influenza B virus, respiratory syncytial virus, parainfluenzavirus-1, parainfluenza-
virus-2, parainfluenzavirus-3 and parainfluenzavirus-4, adenovirus, human metapneumovirus,
coronaviruses 229E, NL63, OC43 and HKU1, enterovirus/rhinovirus and human bocavirus.
The samples that were positive for RSV and negative for other viruses were stored at -80°C.
RSV types and genotypes
The RSV-positive viral nucleic acid extracts were re-tested for confirmation using a single-tube
RT-PCR kit (TaqMan One-Step RT-PCR Master Mix Reagents Kit, Applied Biosystems, New
Jersey, USA) and a 7,900HT real-time PCR system (Applied Biosystems, New Jersey, USA).
The N genes of RSV-A and RSV-B were targeted for the confirmation with primers and probes
with minor modifications, according to Van Elden et al. [25]. Each tube contained a 25 μL reac-
tion mix that included 2.5 μL isolated RNA, 0.9 μM forward primer, 0.9 μM reverse primer and
0.25 μM probe. The primers and probes for the TaqMan amplification of viral RNA are de-
scribed in Table 1.
RSV cDNA was obtained from the extract using MultiScribe reverse transcriptase and ran-
dom hexamers (TaqMan reverse transcription reagents, Applied Biosystems International,
New Jersey, USA). The second hypervariable region of the G protein of the RSV-positive sam-
ples was the target for the genotyping using the forward primer, ABG490 (ATGATTWYCAY
TTTGAAGTGTTC), that corresponds to bases 497–519 of the G protein gene of strain A2
(group A prototype strain, GenBank Acc. No. M11486) and BA4128/99B (group BA prototype
strain, GenBank Acc. No. AY333364) and the reverse primer, F164 (GTTATGACACTGGTA
TACCAACC), that corresponds to bases 164–186 (with one mismatch) of the F protein gene
of strain A2 and bases 164–186 in sequences of strain 18537 (a group B strain, GenBank Acc.
No. D00334) [26, 27].
Total cDNA was used in a PCR under the following conditions: 94°C for 3 min, 40 cycles of
94°C for 35 sec, 50°C for 45 sec, and 72°C for 1 min, followed by final extension at 72°C for
RSV Types and Genotypes Circulation
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10 min. The reaction mixture contained 1x PCR buffer (GE Healthcare, Uppsala, Sweden), 10
mM dNTP, 0.25 mMMgCl2, 0.25 mM of ABG490 and F164 primers, and 5 U of Taq polymer-
ase (GE Healthcare, Uppsala, Sweden). The amplified products of 607/610 bp (group A/B vi-
ruses) and 670 bp (BA viruses) were analysed by means of electrophoresis on a 1.5% agarose
gel and then purified using a QIAquick Gel Extraction Kit (QIAGEN, Venlo, Netherlands).
The sequencing reactions were set up using purified DNA, one of the specific primers used in
the PCR, and the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems Interna-
tional, New Jersey, USA) in accordance with the protocol recommended by the manufacturer.
The sequencing and sequence analyses were performed on a 3130 Genetic Analyser (Applied
Biosystems International, New Jersey, USA). The nucleotide sequence spanned bases 5,274–
5,543 (270 nt) of prototype strain A2; in the case of group B viruses, the sequence corresponded
to bases 652–981 (330 nt) of BA4128/99B, a prototype genotype B strain. All of the alignments
were made using ClustalX 2.1 and BioEdit (version 7.1.3.0) software (Ibis Biosciences, Carls-
bad, CA).
Phylogenetic trees of the G protein gene were generated using the neighbour-joining
method, p-distance model with Molecular Evolutionary Genetics Analyses (MEGA) software,
version 5.05 [28]. Bootstrap probabilities for 1,000 iterations were calculated to evaluate confi-
dence estimates. The graphs were made using GraphPad Prism version 5.01 for Windows
(GraphPAD Software, San Diego, CA). The nucleotide sequences identified in this study have
been submitted to GenBank database with accession numbers KP284582-KP284746.
Selective pressure
Tests for positive selection were conducted using single-likelihood ancestor counting (SLAC),
fixed-effects likelihood (FEL), random effects likelihood (REL), internal branch fixed-effects
likelihood (IFEL), the mixed effects model of evolution (MEME), and fast unconstrained
Bayesian approximation (FUBAR) on the Datamonkey server [29], with the dN/dS ratios being
calculated using the SLAC and FEL codon-based maximum likelihood approaches. SLAC
counts the number of non-synonymous changes per non-synonymous site (dN) and tests
whether it is significantly different from the number of synonymous changes per synonymous
site (dS). FEL estimates the ratios of non-synonymous to synonymous changes for each site in
an alignment [30]. The IFEL method is similar to FEL, but tests for site-by-site selection only
along internal branches of the phylogeny. In order to avoid an excessive false-positive rate,
sites with SLAC, FEL, IFEL and MEME p-values of<0.1 and a FUBAR posterior probability of
>0.90 were accepted as candidates for selection.
Statistical analysis
Descriptive statistics of the responses were generated. The continuous variables are given as
mean values ± standard deviation (SD), and the data were analysed using a two-sided Student’s
Table 1. Primers and probes for the TaqMan real-time PCR used to detect viral RNA from RSV-A and B.
RSV type (target gene) Primer and probe Sequence
A (N gene) RSA-1 5’-AGATCAACTTCTGTCATCCAGCAA-3’
RSA-Rev 5’-TGTGTTTCTGCACATCATAATTAGGA-3’
RSA-probe FAM-ACACCATCCAACGGAGCACAGGAGA-TAMRA
B (N gene) RSB-1 5’-AAGATGCAAATCATAAATTCACAGGA-3’
RSB-Rev 5’-TGATATCCAGCATCTTTAAGTATCTTTATAGTG-3’
RSB probe FAM-AGGTATGTTATATGCTATGTCCAGGTTAGGAAGGGAA-TAMRA
doi:10.1371/journal.pone.0129369.t001
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t test after checking data were normally distributed (based on the Shapiro-Wilk statistic) or a
two-sided Wilcoxon’s rank-sum test otherwise; the categorical variables are given as numbers
and percentages, and the between-group data were compared using contingency table analysis
with the χ2 or Fisher’s exact test, as appropriate. All of the analyses were two tailed, and made
using SAS version 9.2 software (Cary, NC, USA); p-values of0.05 were considered statistically
significant.
Results
Prevalent RSV types and genotypes
Of the 165 exclusively RSV-positive nasopharyngeal samples screened using the respiratory
virus panel and re-confirmed by Taqman Real-Time PCR 131 (79.4%) carried RSV-A and 34
(20.6%) RSV-B. Both groups co-circulated in all of the study periods, with RSV-A predominat-
ing in all the seasons except for 2010–2011, which had a predominance of RSV-B. The distribu-
tion of the RSV strains is shown in Table 2: 29 cases (25 RSV-A, four RSV-B) in 2009–2010;
13 cases (three RSV-A, 10 RSV-B) in 2010–2011; 36 cases (35 RSV-A, one RSV-B) in 2011–
2012; 30 cases (22 RSV-A, eight RSV-B) in 2012–2013; and 57 cases (46 RSV-A, 11 RSV-B) in
2013–2014. No case of co-infection with the two groups was identified.
Phylogenetic analyses and amino acid signatures
Phylogenetic analysis of the RSV-A sequences led to the identification of 61/131 samples
(46.5%) carrying genotype NA1 (blue circles in Fig 1) and 69/131 (52.7%) carrying genotype
ON1 strains (black circles in Fig 1) and 1/131 (0.8%) with undetermined genotype (green circle
in Fig 1). The p-distances within the NA1 and ON1 genotypes were respectively 2.4 ± 0.3% and
2.3 ± 0.5%, and the p-distance between NA1 and ON1 was 5.2 ± 1.2%.
The NA1 strain sequences were characterised by N237D/Y amino acid substitutions, a
change involved in the loss of a potential glycosylation site in position 237. Only three se-
quences (MI-3521-Jan2011, mi-3517-Dec2011, and Mi-73-Dec2011) were observed with a re-
covered N-glycosylation site in positon 237. It is worth noting that two divergent clusters
(highlighted in grey in Fig 1) were identified with several amino acid changes: one character-
ised by amino acid changes P222L, E232G, K233E, K240R and N242S, and the other by amino
acid changes P234S, T239A, I243T, S250T and S277P. RSV-A NA1 was the only genotype
identified in the samples collected during the winter seasons between 2009–2010 to 2011–
2012, but was no longer present in the later samples.
Table 2. RSV types and genotypes detected in the studied nasopharyngeal samples.
No. (%) of samples with the indicated species and genotype
Type and genotype Total 09–10 10–11 11–12 12–13 13–14
RSV-A / NA1 62 (37.6) 25 (40.3) 2 (3.2) 35 (56.5) 0 0
RSV-A / ON1 –group A 29 (17.6) 0 1 (3.5) 0 17 (58.6) 11 (37.9)
RSV-A / ON1 –group A1 16 (9.7) 0 0 0 0 16 (100.0)
RSV-A / ON1 –group B 24 (14.5) 0 0 0 5 (20.8) 19 (79.2)
RSV-B / BA-9 26 (15.8) 4 (15.4) 4 (15.4) 1 (3.8) 6 (23.1) 11 (42.3)
RSV-B / BA-10 8 (4.8) 0 6 (75.0) 0 2 (25.0) 0
Total RSV 165 29 13 36 30 57
p<0.001 (chi-squared test for independence between autumn-winter season and species/genotype)
doi:10.1371/journal.pone.0129369.t002
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A single swab was positive for genotype ON1 in 2011–2012, but this genotype subsequently
completely replaced NA1. The RSV-A strains belonging to the ON1 genotype were character-
ised by amino acid changes E232G, T253K and P290L (RSV-A NA1 numbering). Within the
ON1 genotype, three different phylogenetic subgroups (group A: n = 29 strains; group A1;
n = 16 strains; and group B: n = 24 strains), could be distinguished in the phylogenetic tree
Fig 1. Phylogenetic tree based on partial G gene sequences of RSV-A strains (nt 634–897). The sequences originally found in this study are indicated
by black, blue and green circles (n = 131); the other Italian reference sequences are indicated by red circles (n = 3). The RSV-A reference stains are in bold
(n = 32). Significant amino acid changes are reported along the tree branch or near the strain name. The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. The evolutionary distances were computed using the Tamura-
Nei method.
doi:10.1371/journal.pone.0129369.g001
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shown in Fig 1 on the basis of some amino acid substitutions in comparison with the first-de-
scribed ON1 strain. The sequences belonging to group A were characterised by amino acid
changes L274P, L298P and Y304H, and those in group A1 by the amino acid changes G254E,
Y273H and Y297H; no unique amino acid changes were observed in the sequences belonging
to group B.
Phylogenetic analysis of the samples positive for RSV-B showed that 26/34 (76.5%) be-
longed to genotype BA9 and 8/34 (23.5%) to genotype BA10 (Fig 2A). The first was detected
during all of the studied seasons, whereas BA10 was detected only in the 2010–2011 and 2012–
2013 seasons. All of the RSV-B strains identified in this study carried the 60 nt duplication in
the second hypervariable region of the G protein (Fig 2B): all but one strain had a predicted G
protein length of 312 amino acids, whereas strain MI-95-Dec2011 had a G protein length of
Fig 2. (A) Phylogenetic tree based on partial G gene sequences of RSV-B strains (nt 637–897). The
sequences originally found in this study are indicated by black circles (n = 34). The RSV-B reference stains
are in bold (n = 55). The percentage of replicate trees in which the associated taxa clustered together in the
bootstrap test (1000 replicates) are shown next to the branches. (B) Alignment of deduced G protein amino
acid sequence of RSV-B strains. The gaps are indicated by dashes (-) and the conserved amino acid
residues by dots (.). The length of the G gene is shown at the end of the sequence of each strain. The amino
acids included in glycosylation sites are highlighted by grey boxes.
doi:10.1371/journal.pone.0129369.g002
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319 amino acids. In addition, a number of non-synonymous amino acid substitutions were ob-
served in the duplicated region (indicated in bold in Fig 2B). The p-distances in genotypes GB9
and GB10 were respectively 3.5 ± 0.7% and 1.0 ± 0.4%, whereas the p-distance between GB9
and GB10 was 7.4 ± 1.7%. The nucleotide sequences identified in this study have submitted to
GenBank database with accession numbers KP284582-KP284746.
Analyses of selective pressure
A global analysis of selective pressure made using the SLAC model indicated an estimated
overall dN/dS ratio of 0.81 for RSV-A and 0.67 for RSV-B. Overall, the site-specific analyses
identified two sites (274, 310) in the RSV-A and one (270) in the RSV-B alignment as being
under positive selection by at least three of the methods used (SLAC, FEL, REL, FUBAR and
MEME). Site 270 was included in the 60 nt duplication region of the RSV-B strains. A number
of negatively selected sites were identified in both the RSV-A and RVS-B G protein alignment
by means of different methods (Table 3).
The IFEL model used to determine the selection pressure acting on the codons along the in-
ternal branches of the tree identified four positively selected codons (237, 274, 298, and 310) in
the RSV-A sequences. This reflects the amino acid changes observed in the sequences of geno-
type NA1 (Fig 1), particularly the amino acid signatures representative of the sequence evolu-
tion of clusters A and A1 (L274P, L298P and L310P).
Association between RSV types/genotypes and disease severity
Table 4 shows the demographic, clinical and laboratory data relating to the infected children.
There were no statistically significant differences in any of the studied variables between those
infected by RSV-A and those infected by RSV-B. Age and clinical manifestations of RSV infec-
tion were similar in the two groups, as were the hospitalisation rates, the duration of hospital
stays, and all of the laboratory variables except for the white blood cell count, which was higher
in the children with RSV-A infection.
However, comparison of the children infected by genotypes A/NA1 and A/ON1 showed
that LRTI was more frequently diagnosed in those with A/NA1 infection (p<0.0001), who
were also more frequently hospitalised (p = 0.007); moreover, their white blood cell counts
Table 3. Positive and negative selected sites for RSV-A and RSV-B strains identified in this study.
Methods RSV-A codon RSV-B codon
Positive Negative Positive Negative
SLAC 274, 298 227, 294 None 216, 285
FEL 274, 310 223, 227, 256,
266
270 216, 223, 249, 269, 285, 295, 304
REL 262, 274, none 270 214, 216, 220, 223, 229, 238, 246, 249, 250, 253, 256, 257, 264, 269, 272, 285, 295, 299,
304, 307, 311, 312
FUBAR 262, 274 227, 239, 256,
266
270,
292
216, 223, 249, 269, 285, 295, 304
MEME 244, 274 none 270,
297
None
IFEL 237, 274, 298,
310
239, 280 219 216, 285
FEL: ﬁxed-effects likelihood; FUBAR: fast unconstrained Bayesian approximation; IFEL: random effects likelihood; MEME: mixed effects model of
evolution; REL: internal branch ﬁxed-effects likelihood; SLAC: single-likelihood ancestor.
doi:10.1371/journal.pone.0129369.t003
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included a significantly higher number of lymphocytes (p = 0.03) and monocytes (p = 0.04).
On the contrary, there was no difference in the clinical characteristics of the children infected
by the three phylogenetic subgroups in the A/ON1 strain, or between those of the children
with B/BA9 or B/BA10 infection (data not shown). However, the infections due to B strains
were globally more severe than those due to A/ON1 because the children with B viruses were
more frequently affected by LRTIs and more frequently hospitalised (Table 3).
Discussion
The findings of this study show that RSV has complex circulation patterns that are character-
ised by the periodic replacement of the predominant genotypes with new ones during succes-
sive epidemic seasons. As previously found in other countries [13,17–21] and Central Italy
Table 4. Comparison of individual RSV infections by demographic, clinical and laboratory variables.
Characteristic RSV-A
n = 131
RSV-B
n = 34
P value A vs
B
RSV- A/NA1
n = 62
RSV- A/ON1
n = 69
P value A/NA1 vs A/
ON1
n/N (%) n/N (%) n/N (%) n/N (%)
Demographic and clinical
presentation
Males (%) 79 (60.3) 22 (64.7) 0.78 35 (56.5) 44 (63.8) 0.49
Mean age ± SD, yrs 0.87 ± 0.81 0.97 ± 1.06 0.82 0.88 ± 0.65 0.86 ± 0.93 0.21
Presence of fever” (%) 126 (96.2) 30 (88.20) 0.08 59 (95.2) 67 (97.1) 0.66
High-grade fever° (%) 83 (63.3) 15 (44.1) 0.06 45 (72.6) 38 (55.1) 0.05
Respiratory rate, bpm 50.0 ± 13.4 42.2 ± 9.9 0.43 52.3 ± 9.3 47.9 ± 16.5 0.52
Mean SpO2 in room air ± SD, % 95.9 ± 2.8 97.3 ± 2.7 0.88 96.4 ± 2.5 95.0 ± 3.0 0.79
Diagnosis
Upper respiratory tract infection 59 (45.0) 15 (44.1) 0.92 10 (16.1) 49 (71.0) <0.0001
Lower respiratory tract infection 72 (55.0) 19 (55.9) 52 (83.9) 20 (29.0)
Clinical outcome
Hospitalisation, No.(%) 45 (34.3) 16 (47.0) 0.24 29 (46.8) 16 (23.2) 0.007
Mean duration of hospitalisation,
days ± SD
5.7 ± 2.5 6.8 ± 1.8 0.06 5.6 ± 2.7 6.0 ± 2.1 0.32
Drug use, No. (%)
Antibiotics 126 (96.1) 34 (100.0) 0.58 59 (95.2) 67 (97.1) 0.66
Antipyretics 126 (89.0) 30 (88.2) 0.08 61 (98.4) 65 (94.2) 0.36
Aerosol therapy 120 (91.6) 27 (82.3) 0.06 57 (91.9) 63 (91.3) 0.85
Mean absence from community,
days ± SD
10.1 ± 4.2 16.5 ± 12.0 0.08 10.9 ± 4.7 8.2 ± 2.0 0.44
Similar illness within the family 62 (47.3) 19 (55.9) 0.48 27/62 (43.5) 13/23 (56.5) 0.29
Laboratory data
White blood cell count, cells/μL 11453 ± 4361 9208 ± 2511 0.05 11248 ± 4840 11997 ± 2770 0.29
Neutrophils, % 42.9 ± 17.2 46.5 ± 13.0 0.40 39.4 ± 16.0 51.8 ± 17.4 0.02
Lymphocytes, % 43.3 ± 14.5 40.9 ± 12.2 0.71 44.4 ± 14.0 21.7 ± 5.2 0.03
Monocytes, % 13.6 ± 4.8 12.6 ± 3.9 0.65 13.9 ± 4.8 8.7 ± 2.3 0.04
Basophils, % 0.4 ± 0.3 0.5 ± 0.7 0.90 0.4 ± 0.4 0.5 ± 0.2 0.71
Eosinophils, % 0.4 ± 0.5 0.5 ± 0.4 0.64 0.4 ± 0.5 0.1 ± 0.1 0.76
CRP, μg/dL 16.9 ± 80.8 2.6 ± 3.8 0.56 3.4 ± 4.7 47.6 ± 144.1 0.48
bpm, beats per minute; CRP, C-reactive protein; SD, standard deviation; SpO2, peripheral oxygen saturation.”38.0°C any time during illness (before or
upon enrolment, or during follow-up); 39.0°C any time during illness (before or upon enrolment, or during follow-up).
doi:10.1371/journal.pone.0129369.t004
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[16], the new RSV-A/ON1 strain emerged in Northern Italy in 2011–2012, and soon complete-
ly replaced the previously dominant RSV-A/NA1 strain. In addition, as recently occurred in
Japan [10], RSV-B/BA9 was predominant between RSV-B viruses. It was identified in all the
years of the study, whereas detection of RSV-B/BA10 was limited to 2010–2011 and 2012–
2013 seasons. Phylogenetic and deduced amino acid sequence analyses of the RSV strains re-
vealed that ongoing changes characterised the different clusters in the RSV-A tree [31,32]. In-
terestingly, almost all of the Italian NA1 strains lost the first N-glycosylation site due to
substitution N237D [5], whereas this N-glycosylation site was restored in three NA1 and all
ON1 strains. The NA1 strains fell into two clusters characterised by a number of amino acid
changes, but it is not clear how these changes favoured the evasion of the host immune re-
sponse. The ON1 genotype was characterised by E232G, T253K and P292L substitutions, as
previously reported in Chinese strains [33], and other cluster-specific mutations were observed
in ON1 clusters A (L274P, L298P and 310P) and A1 (G254E, Y273H, and Y297H) [18,34].
It has been suggested that the evolution of the major antigens of RSV and other respiratory
viruses is associated with selective pressure due to host immune responses [35]. Our search for
phylogenetic signatures of selective pressure in RSV-A and RVS-B showed that the RSV genes
have predominantly negatively or neutrally selected evolving sites. Only a minority were under
positive selection, thus suggesting that the forces driving the evolution of RSV are mainly sto-
chastic. However, additional investigations are needed to evaluate whether amino acid changes
in the G protein may help the virus to alter the antigenic characteristics leading to an evolution-
ary advantage.
The estimated overall mean dN/dS ratios of both RSV-A and RSV-B were in line with those
reported by other authors [33,36]. Substitutions at positions 274 and 286 (corresponding to
310 in our RSV-A alignment) have previously been associated with antibody escape [35,37].
The IFEL method indicated that the RSV-A and RSV-B sequences had respectively four and
two codons under positive selection pressure and, in agreement with other reports [38], this
finding suggests a variation within the lineage corresponding to emerging RSV genotypes.
In this study, only children exclusively infected by RSV were included. This permitted to
have precise information regarding the real pathogenic role of this virus avoiding the risk of
misinformation that can occur when all the RSV infections, including co-infections between
RSV and other respiratory viruses, are studied. However, only children aged< 2 years attend-
ing the Emergency Room were enrolled. Moreover, in comparison to RSV-B, a significant
greater number of RSV-A positive cases was identified. These are limits that do not allow to
draw firm conclusions about the real global clinical relevance of the different RSV types in pae-
diatrics. RSV infection is more severe in younger children and mild to moderate infections are
usually followed by primary care paediatricians in the community [1]. However, in the study
population, we did not find any difference in the severity of the disease due to RSV-A and
RSV-B strains. This finding is in line those of some previous studies [39–41], but conflicts with
those of other epidemiological evaluations showing a significantly higher risk of severe disease
due to type A [42–45] or type B [46]. Moreover, it is not agree with findings in various cell cul-
ture and in vivomodels suggesting that individual RSV-A strains may be more infective, viru-
lent and immunopathogenic [1]. In this regard, it is interesting to note the findings of a recent
in vitro study of primary epithelial cells and epithelial cell lines, which suggest that prototypical
RSV-A and RSV-B strains are differently capable of inducing nuclear factor-κB (NF-κB) acti-
vation (i.e. an important step in the cascade of events leading to the production of pro-inflam-
matory cytokines) and the subsequent induction of the NF-κB responsive genes interleukin
(IL)-6 and IL-8, with RSV-B eliciting significantly weaker responses than RSV-A [47].
These conflicting results may be due to differences in study design, disease definition, inclu-
sion criteria, or genotyping methodology, but they may also be at least partially explained by a
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real difference in the pathogenic role of some particular genotypes. The greater severity of the
infections due to RSV-A/NA1 in comparison with RSV-A/ON1 suggest that different RSV ge-
notypes may be associated with different degrees of virulence, and that the relevance of one
RSV type in clinical practice may depend on the incidence of infections due to the most viru-
lent genotype during the period of the epidemiological evaluation. A simple evaluation of RSV
type is not enough to predict the risk of severe infection during epidemics, and only studies
specifically planned to evaluate the virulence of the different genotypes can allow a precise as-
sessment of what can be expected when a particular genotype is in circulation.
We found that RSV-A/ON1 was significantly less virulent than genotype A/NA1, as shown
by the lower incidence of LRTIs and less frequent hospitalisation of A/ON1-infected children.
This is in line with the findings of other authors [16,17,31,48], although Prifert et al. observed
that a considerable number of children with A/ON1 infection were admitted to an intensive
care unit [31], possibly because they only enrolled children with LRTIs. The lower virulence of
A/ON1 also seems to be further supported by our finding that the clinical manifestations due
to A/ON1 infection were significantly less severe than those due to the simultaneously circulat-
ing B/BA9 and B/BA10 viruses. Similar data have been reported by Panayiotou et al. [48], who
showed that patients infected with RSV-A/ON1 had a significantly lower mean severity score
than children with B/BA infection.
In conclusion, the findings of this study highlight the value of investigating the circulation
of RSV strains and evaluating the different pathogenic roles of the various genotypes during
mild and severe RSV infection because each individual strain can have a different impact on
the host. A knowledge of the correlations between types, genotypes and disease severity may
also be important in order to be able to include the more virulent strains in future vaccines.
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